Skip to content

Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01678274
Acronym
TSCORII
Enrollment
106
Registered
2012-09-03
Start date
2013-12-31
Completion date
2016-10-31
Last updated
2016-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Congenital Heart Defect, Hypertension, Ischemic Heart Disease, Turner Syndrome

Keywords

Turner Syndrome, Aortic Aneurysm, Ischemic heart disease, Hypertension, Congenital Heart Defect, Pulse Wave Velocity, Augmentation Index, Central Blood Pressure, Agatston Score, Segment involvement score

Brief summary

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general. Our study aim is: * Using MRI to further characterize and find risk factors leading to aortic dilation. * Using MRI to assess the degree of aortic distensibility. * Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies. * Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Detailed description

Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, congenital heart defects, hypertension, stroke, ovarian failure, infertility, decreased final height and autoimmune diseases in general Our study aim is: * Using MRI to further characterize and find risk factors leading to aortic dilation. * Using MRI to describe aortic dimensions * Using MRI to assess the degree of aortic distensibility. * Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies. * Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.

Interventions

None listed

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

with respect to individuals acting as controls: * Healthy age matched females

Exclusion criteria

* Contraindications for MRI * Contraindications for CT * Severe obesity * Acute og Chronic disease with known or presumed significance with concern to outcomes of the study * Previous or present malignant disease * Clinically significant liver disease * Mechanic or biological heart valves

Design outcomes

Primary

MeasureTime frameDescription
Aortic distensibilityOnceAortic distensibillity as measured by MRI
Aortic dimensionsOnceAortic dimensions measured by MRI
Agatston scoreOnceCoronary CT evaluation of Agatston score
Segment involvement scoreOnceSegment involvement score (SIS) calculated as the sum of segments with one or more coronary plaques (score 0-18).

Secondary

MeasureTime frameDescription
Central blood pressureOnceCentral blood pressure measured by applanation tonometry.
24 hour blood pressure24 hour24 hour blood pressure
Pulse Wave VelocityOncePulse Wave Velocity measured by applanation tonometry.
Augmentation indexOnceAugmentation index measured by applanation tonometry.

Other

MeasureTime frameDescription
echocardiographyOnceechocardiography evaluating Mitral and aortic valves, left ventricular hypertrophy, diastolic and systolic function etc..

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026